- email:registrations@informa-ls.com
- phone:+44(0)20 7017 7481
 |
13th Annual
Phase I & IIa Clinical Trials
21 - 22 February 2012
|
Contact us
For information about registering, delegate information or any other customer service enquiries, please contact:
Customer Services Informa Life Sciences
Tel: +44(0)20 7017 7481
Fax: +44(0)20 7017 7823
Email: registrations@informa-ls.com
For speaker information, please contact:
Sarah Palit
29 Bressenden PlaceLondonSW1E 5DR
Tel: +44 (20) 701 75371
Fax: + 44 (20) 701 5656
Email: sarah.palit@informa.com
For information about exhibition opportunities please contact:
Sukhvir Hayre
29 Bresseden Place, London SW1E 5DR,United Kingdom
Tel: +44 (0) 20 7017 7240
Email: sukhvir.hayre@informa.com
For information about sponsorship opportunities please contact:
Sukhvir Hayre
29 Bresseden Place, London SW1E 5DR,United Kingdom
Tel: +44 (0) 20 7017 7240
Email: sukhvir.hayre@informa.com
For information about upcoming conferences and/or speaking opportunities contact:
Customer Services Informa Life Sciences
Tel: +44(0)20 7017 7481
Fax: +44(0)20 7017 7823
Email: registrations@informa-ls.com
With any difficulties/comments regarding website please contact:
Samantha Mace
29 Bressenden Place, London, SW1E 5DR
Tel: +44 (0) 20 7017 7130
Fax: +44 (0) 20 7017 5656
Email: smace@pti-europe.co.uk
Event write up 2012
Missed the event?
"Graham Hughes reviews the 13th Annual Phase 1 and 2a Clinical Trials conference,
highlighting key presentations on proof of concept and venture capital initiatives . . ."
Read the full article by clicking here
Keynote Speakers
Senior level industry decision makers including perspectives from large pharma, biotech, venture capital and financial analysts.
Click here for a full list of expert speakers
Keynote Speakers
Greg Simon
Senior Vice President, Patient Engagement Group
Pfizer
|
Paul de Koning
Vice President, Head Global Clinical Pharmacology & Exploratory Development
Astellas Pharma Global Development
|
Steve Street
Vice President for Research, Head of Pfizer R&D Continuous Improvement
Pfizer
|
James Noble
CEO
Immunocore
|
Joseph DeGeorge
Vice President, Safety Assessment
Merck Research Laboratories
|
Tony Johnson
Vice President, Discovery Medicine Clinical Pharmacology
Bristol-Myers Squibb Research
|
Kate Bingham
Managing Partner
SV Life Sciences
|
Douglas Tsao, MPH
U.S. Specialty Pharmaceuticals & CROs
Barclays Capital Equity Research
|
Stephen Unger, CFA
Director / Senior Analyst, Equity Research - Life Science Tools & Diagnostics
Lazard Capital Markets
|
Neil V. Smith
Director Regulatory Affairs
Chorus, Lilly Research Laboratories, Eli Lilly and Company, USA
|
Feeds | Like | Share    |
Latest Agenda
Download the latest agenda
Updated 14 Feb 2012
FREE Wine Tasting Evening
Join the discussions
Follow us
Buy one 2 day conference pass and get one free*
Brand new offer for 2012!
We want to make sure that you are able to attend this important industry event
*offer applicable to employees of pharmaceutical and biotech companies only
Brand new for 2012: Site Visit!
Visit the Clinical Trials Centre at St. Mary's Hospital, Imperial College Healthcare NHS Trust
Free to attend - limited space available so make sure you register and quote CQ4156D
Latest tweets
Dates and Venues
21 Feb 2012 - 22 Feb 2012
The Lancaster London
Event Sponsors
Exhibitors
